Florian Roghmann

8PUBLICATIONS
74CO-AUTHORS
Predictive and prognostic markersMolecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 13, 2025
Upstaging of Patients Diagnosed with Favorable Intermediate-Risk Prostate Cancer-Is Active Surveillance Really a Suitable Approach for All These Patients?

Analena E Handke, Christopher Orf, Martina Dellino

|Jan 23, 2024
Use of Multiple Machine Learning Approaches for Selecting Urothelial Cancer-Specific DNA Methylation Biomarkers in Urine.

Christina U Köhler, Karin Schork, Michael Turewicz

|Oct 27, 2023
Influence of the Anesthetic Technique on Circulating Extracellular Vesicles in Bladder Cancer Patients Undergoing Radical Cystectomy: A Prospective, Randomized Trial.

Luisa Gluth, Crista Ochsenfarth, Phuong Nam Viet Pham

|Dec 19, 2022
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.

Niklas Klümper, Damian J Ralser, Jörg Ellinger

|Sep 22, 2022
Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate.

Ekaterina Laukhtina, Marco Moschini, Wojciech Krajewski

|Jun 24, 2022
Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment-A Retrospective Multicenter Analysis.

Felix Riedel, Mara Münker, Florian Roghmann

Pageof 2

Frequent Collaborators

1 joint publications

Malte W Vetterlein

1 joint publications

Atiqullah Aziz

1 joint publications

Karl H Tully

1 joint publications

Julian Hanske